ABL vs CITE
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABL is a Hold and CITE is a Sell.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
ABL’s FA Score shows that 1 FA rating(s) are green whileCITE’s FA Score has 1 green FA rating(s).
- ABL’s FA Score: 1 green, 4 red.
- CITE’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
ABL’s TA Score shows that 5 TA indicator(s) are bullish.
- ABL’s TA Score: 5 bullish, 3 bearish.
Price Growth
ABL (@Life/Health Insurance) experienced а +2.71% price change this week, while CITE (@Financial Conglomerates) price change was +0.09% for the same time period.
The average weekly price growth across all stocks in the @Life/Health Insurance industry was +0.62%. For the same industry, the average monthly price growth was +1.54%, and the average quarterly price growth was +10.93%.
The average weekly price growth across all stocks in the @Financial Conglomerates industry was +0.60%. For the same industry, the average monthly price growth was +0.20%, and the average quarterly price growth was +21.67%.
Reported Earning Dates
ABL is expected to report earnings on Apr 18, 2023.
CITE is expected to report earnings on Mar 31, 2023.
Industries' Descriptions
@Life/Health Insurance (+0.62% weekly)Life insurance companies mainly sell policies that pay a death benefit as a lump sum upon the death of the insured to their beneficiaries. Life insurance policies may be sold as term life, (which guarantees payment of a stated death benefit and expires at the end of a specified term) or permanent /typically whole life (which is more expensive but lasts a lifetime and carries a cash accumulation component). Life insurance firms may also sell long-term disability policies that help to replace the insured individual’s income if they become sick or disabled. Health insurance, on the other hand, helps pay for medical expenses. Anthem, Inc., MetLife, Inc. and Aflac Incorporated are some of the largest U.S. companies in this industry.
@Financial Conglomerates (+0.60% weekly)Financial conglomerates usually encompass a wide range of financial services including (not necessarily limited to) investment banking, insurance, capital raising/underwriting, trading of financial securities, investment advisory services, wealth management of high net-worth individuals, and retail banking. Think Citigroup, American Express Company, ING Group.
| ABL | CITE | ABL / CITE | |
| Capitalization | 776M | 111M | 699% |
| EBITDA | 23.8M | -1.8M | -1,323% |
| Gain YTD | -9.834 | 6.141 | -160% |
| P/E Ratio | 76.28 | 39.35 | 194% |
| Revenue | 66.4M | 0 | - |
| Total Cash | 27.8M | 21.3K | 130,516% |
| Total Debt | 142M | 100K | 142,000% |
| ABL | |
|---|---|
| RSI ODDS (%) | 2 days ago 50% |
| Stochastic ODDS (%) | 2 days ago 37% |
| Momentum ODDS (%) | 2 days ago 33% |
| MACD ODDS (%) | 2 days ago 28% |
| TrendWeek ODDS (%) | 2 days ago 27% |
| TrendMonth ODDS (%) | 2 days ago 29% |
| Advances ODDS (%) | 15 days ago 54% |
| Declines ODDS (%) | 8 days ago 51% |
| BollingerBands ODDS (%) | 2 days ago 42% |
| Aroon ODDS (%) | 2 days ago 41% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| CDIVX | 14.31 | 0.20 | +1.42% |
| Copeland Dividend Growth Fund Class I | |||
| JDEUX | 46.38 | 0.20 | +0.43% |
| JPMorgan US Research Enhanced Equity R6 | |||
| RGECX | 10.44 | 0.04 | +0.38% |
| Russell Inv Global Equity C | |||
| BRXIX | 13.65 | 0.02 | +0.15% |
| MFS Blended Research Intl Eq I | |||
| CIISX | 14.99 | N/A | N/A |
| Causeway International Small Cap Instl | |||
ABL and
Correlation & Price change
A.I.dvisor indicates that over the last year, ABL has been loosely correlated with ADRT. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if ABL jumps, then ADRT could also see price increases.
| Ticker / NAME | Correlation To ABL | 1D Price Change % | ||
|---|---|---|---|---|
| ABL | 100% | -1.69% | ||
| ADRT - ABL | 43% Loosely correlated | N/A | ||
| MITAU - ABL | 39% Loosely correlated | N/A | ||
| CITE - ABL | 37% Loosely correlated | +0.17% | ||
| NSTC - ABL | 34% Loosely correlated | N/A | ||
| TGAA - ABL | 29% Poorly correlated | -0.09% | ||
More | ||||
CITE and
Correlation & Price change
A.I.dvisor indicates that over the last year, CITE has been loosely correlated with CITEU. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if CITE jumps, then CITEU could also see price increases.
| Ticker / NAME | Correlation To CITE | 1D Price Change % | ||
|---|---|---|---|---|
| CITE | 100% | +0.17% | ||
| CITEU - CITE | 47% Loosely correlated | N/A | ||
| ABL - CITE | 37% Loosely correlated | -1.69% | ||
| ONYX - CITE | 36% Loosely correlated | N/A | ||
| HYAC - CITE | 32% Poorly correlated | -0.46% | ||
| FORLU - CITE | 30% Poorly correlated | N/A | ||
More | ||||